Literature DB >> 26974442

Correction: Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis.

.   

Abstract

Entities:  

Year:  2016        PMID: 26974442      PMCID: PMC4790887          DOI: 10.1371/journal.pone.0151752

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
Fig 5 appears incorrectly in the published article. Please see the complete, correct Fig 5 and its legend here. The publisher apologizes for the error.
Fig 5

Decreased TUSC3 expression promotes tumor cell growth, migration and invasion.

(A, B) TUSC3 is effectively knocked-down in Colo357 cell lines shown by (A) RT-PCR and (B) Western blot. (C, D) Proliferation is enhanced with TUSC3 knockdown, cell number counts are significantly different at 72 hours (Colo357 TUSC3 shRNA2 vs Colo357 Scramble p = 0.0086, Colo357 TUSC3 shRNA3 vs Colo357 Scramble p = 0.0011) (D). (E, F) Colony Formation is enhanced with TSUC3 knockdown (Colo357 TUSC3 shRNA2 vs Colo357 Scramble p<0.0001, Colo357 TUSC3 shRNA3 vs Colo357 Scramble p<0.0001). (G) Migration Test (Colo357 TUSC3 shRNA2 vs Colo357 Scramble p<0.0001, Colo357 TUSC3 shRNA3 vs Colo357 Scramble p<0.0001). (H, I) Invasion Test (Colo357 TUSC3 shRNA2 vs Colo357 Scramble p<0.0001, Colo357 TUSC3 shRNA3 vs Colo357 Scramble p<0.0001). (J) Wound healing test showed more rapid closure of the gap in TUSC3 silenced cells. All experiments were performed three times with representative figures shown as above.

Decreased TUSC3 expression promotes tumor cell growth, migration and invasion.

(A, B) TUSC3 is effectively knocked-down in Colo357 cell lines shown by (A) RT-PCR and (B) Western blot. (C, D) Proliferation is enhanced with TUSC3 knockdown, cell number counts are significantly different at 72 hours (Colo357 TUSC3 shRNA2 vs Colo357 Scramble p = 0.0086, Colo357 TUSC3 shRNA3 vs Colo357 Scramble p = 0.0011) (D). (E, F) Colony Formation is enhanced with TSUC3 knockdown (Colo357 TUSC3 shRNA2 vs Colo357 Scramble p<0.0001, Colo357 TUSC3 shRNA3 vs Colo357 Scramble p<0.0001). (G) Migration Test (Colo357 TUSC3 shRNA2 vs Colo357 Scramble p<0.0001, Colo357 TUSC3 shRNA3 vs Colo357 Scramble p<0.0001). (H, I) Invasion Test (Colo357 TUSC3 shRNA2 vs Colo357 Scramble p<0.0001, Colo357 TUSC3 shRNA3 vs Colo357 Scramble p<0.0001). (J) Wound healing test showed more rapid closure of the gap in TUSC3 silenced cells. All experiments were performed three times with representative figures shown as above.
  1 in total

1.  Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis.

Authors:  Xiaoqiang Fan; Xiu Zhang; Jie Shen; Haibin Zhao; Xuetao Yu; Yong'an Chen; Zhuonan Zhuang; Xiaolong Deng; Hua Feng; Yunfei Wang; Long Peng
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

  1 in total
  3 in total

1.  Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells.

Authors:  Yu Zhang; Rong-Quan He; Gang Chen; Ting-Qing Gan; Yi-Wu Dang; Xiu-Ling Zhang; Xiao Wang; Su-Ning Huang; Wen-Ting Huang; Meng-Tong Jiang; Xiao-Ning Gan; You Xie; Ping Li; Dian-Zhong Luo
Journal:  Cancer Cell Int       Date:  2016-12-01       Impact factor: 5.722

2.  TUSC3 as a potential biomarker for prognosis in clear cell renal cell carcinoma.

Authors:  Youji Yan; Zhongjun Chen; Yixiang Liao; Jiajie Zhou
Journal:  Oncol Lett       Date:  2019-03-19       Impact factor: 2.967

3.  TUSC3 inhibits cell proliferation and invasion in cervical squamous cell carcinoma via suppression of the AKT signalling pathway.

Authors:  Fei Sun; Qiuling Jie; Qi Li; Yunjian Wei; Hong Li; Xiaojing Yue; Yanlin Ma
Journal:  J Cell Mol Med       Date:  2022-02-09       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.